Enjoy complimentary customisation on priority with our Enterprise License!
The nucleic acid amplification (NAA) market size is forecast to increase by USD 800.2 million, at a CAGR of 4.5% between 2024 and 2028. The Nucleic Acid Amplification (NAA) market is experiencing significant growth due to increasing research and development (R&D) activities at academic institutes and medical organizations. The advancement of new biotechnological techniques, such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), is driving market expansion. Research in various fields such as molecular biology, microbiology, biochemistry, immunology, genetics, and cell biology is carried out to understand human biology and develop novel medicines and effective treatments for cancer, tuberculosis, and other pathogen diseases. However, challenges persist, including the lack of a skilled workforce to handle these complex technologies and the high cost of NAA equipment and reagents. Moreover, regulatory requirements and reimbursement policies also impact market growth. Despite these challenges, the market is expected to continue its upward trajectory due to the increasing demand for early and accurate diagnosis of genetic disorders and infectious diseases.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The target amplification segments is estimated to witness significant growth during the forecast period. The most widely used nucleic acid amplification method is target amplification, also known as polymerase chain reaction (PCR). The technique relies on the activity to amplify the polymerase, such as deoxyribonucleic acid (DNA), messenger RNA (mRNA), mitochondrial DNA (mtDNA), ribosomal RNA (rRNA), cytosolic DNA, and a series of noncoding RNAs (ncRNAs). This technique of nucleic acid amplification is significantly utilized for detecting and identifying the genetic material in the specimen in molecular diagnostic laboratories nowadays.
Get a glance at the market share of various regions Download the PDF Sample
The target amplification segments accounted for USD 1.18 billion in 2018 and showed a gradual increase during the forecast period. The target amplification technique has increasingly opted for molecular biology diagnoses, which are required to carry out biotechnology research. Similarly, pharmaceutical companies are also opting for target amplification techniques to discover and develop new drugs, owing to the increasing prevalence of chronic and infectious diseases globally.
For more insights on the market share of various regions Download PDF Sample now!
Europe is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Another region offering significant growth opportunities to vendors is Europe. The presence of a large number of testing laboratories, research facilities, sub-contract laboratories, and pharmaceutical companies will facilitate the nucleic acid amplification market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
In the realm of modern medicine, TB cases and their management have seen significant advancements. The introduction of nucleic acid tests, like the Procleix Plasmodium test, enhances diagnostic accuracy, especially in detecting malaria co-infections. For patients undergoing organ transplant or stem cell transplant, these advanced diagnostic tools are crucial for monitoring and preventing complications. The rise of gene-based drugs is also transforming treatment options, offering targeted therapies that can improve outcomes for transplant recipients and those with chronic conditions. With the integration of Medicare and other health insurance programs, access to these cutting-edge treatments and diagnostics has become more feasible for many patients. Furthermore, the development of POC tests (point-of-care tests) allows for rapid detection of various infections, including the novel coronavirus, facilitating quicker response and management. This combination of innovative diagnostics and treatments reflects a significant leap in personalized and effective healthcare solutions. The nucleic acid amplification market is experiencing growth due to the increasing use of enzymes that enhance the efficiency and accuracy of diagnostic tests and research applications.
Increasing research and development (R&D) activities at academic institutes and medical organizations is notably driving market growth. Nucleic acid amplification techniques play a pivotal role in academic institutions and medical organizations for research applications in various fields such as molecular biology, microbiology, biochemistry, immunology, genetics, and cell biology. These organizations conduct research studies on genetic disorders, gene-based drugs, and bioinformatics, which require the amplification of nucleic acids.
Moreover, the adoption of nucleic acid amplification techniques is further boosted by diagnostic devices like RT-PCR testing and POC tests, which are extensively used for infectious diseases such as HIV, Influenza, and the Novel coronavirus. Hospitals and reference laboratories utilize these tests for blood screening and hemoglobin level analysis. The geriatric population, with an increased susceptibility to genetic disorders and infectious diseases, further fuels the demand for nucleic acid amplification kits and reagents. Blood banks also rely on these techniques to ensure the safety and quality of blood transfusions by detecting contaminants. Thus, such factors are driving the growth of the market during the forecast period.
Increasing investment in development of new biotechnological techniques is the key trend in the market. Nucleic acid amplification has become a crucial technology in disease diagnosis, particularly for molecular infectious diseases. Hospitals, diagnostic centers, academic institutes, and research organizations are increasingly utilizing this technique for pathogen detection and viral load monitoring. RT-PCR testing, a common nucleic acid amplification method, is widely used for the diagnosis of various diseases such as HIV, influenza, and the novel coronavirus. The availability of POC tests based on nucleic acid amplification has further expanded its application in various settings.
Moreover, the development of gene-based drugs and the increasing prevalence of genetic disorders have increased the demand for kits and reagents used in nucleic acid amplification. Blood screening, including hemoglobin level testing, also benefits from this technology. Contamination control remains a significant challenge in nucleic acid amplification, and vendors offer solutions in the form of specialized kits and equipment. Blood banks also use nucleic acid amplification for pathogen detection to ensure the safety of the blood supply. The geriatric population, with a higher susceptibility to various diseases, is another significant end-user of nucleic acid amplification technology. Thus, such trends will shape the growth of the market during the forecast period.
Lack of skilled workforce to handle is the major challenge that affects the growth of the market. Nucleic acid amplification is a crucial diagnostic technique used in identifying various diseases, including the novel coronavirus, HIV, influenza, and genetic disorders. Diagnostic devices that utilize this technology, such as RT-PCR testing and POC tests, are essential in hospitals and reference laboratories for accurate and timely diagnosis. Kits and reagents are vital components of these diagnostic tools, ensuring efficient amplification and detection of specific nucleic acid sequences. Skilled professionals, such as pathologists and clinicians, play a pivotal role in carrying out these tests. Their expertise in understanding molecular mechanisms of diseases enables effective patient treatment.
However, the lack of comprehensive training programs for nucleic acid amplification tests is a significant barrier to the workforce expansion in this field. Moreover, safe handling of clinical samples, including blood screening for hemoglobin levels and blood bank applications, is crucial to prevent contamination and maintain the integrity of the samples. The geriatric population, with its unique healthcare needs, further necessitates the availability of skilled professionals in this area. In summary, the demand for professionals proficient in nucleic acid amplification techniques is growing, with a need for ongoing education and training to meet the increasing diagnostic requirements in various healthcare settings. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories: The company offers nucleic acid amplification platform namely Abbott RealTime SARS CoV 2 Amplification reagent kit.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
In global public health, timely diagnosis of diseases such as HIV/AIDS, tuberculosis (TB), hepatitis, and other sexually transmitted infections is crucial. Diagnostic methods have evolved, with biotechnological diagnostic techniques like nucleic acid amplification testing and isothermal nucleic acid amplification technology improving accuracy. Point-of-care testing and portable POC tests facilitate sensitive and energy-efficient diagnostics, especially in diagnostic laboratories and reference laboratories. Diagnostic devices and kits and reagents such as primers, probes, and assay systems, including loop-mediated isothermal amplification and RT-PCR testing, are vital for detecting pathogens. For infectious disease diagnosis, molecular in vitro diagnostic tests are used extensively. Healthcare systems benefit from personalized medicine and genetic testing, which support cancer screening and genetic testing coverage. Addressing public health emergencies and managing diseases like malaria and cytomegalovirus (CMV) involves integrating blood screening and blood donors into care strategies, with a focus on patient care and the geriatric population.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
133 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
|
Market growth 2024-2028 |
USD 800.2 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.23 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
Europe at 38% |
|
Key countries |
US, Germany, China, UK, and Canada |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Ustar Biotechnologies Hangzhou Ltd., Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Science Group Holdings Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidelortho Corp., Siemens AG, Tecan Trading AG, and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market forecasting growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Technique
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
